To strengthen the overall development of cancer treatment and precision medicine, a Memorandum of Understanding (MOU) for industry-academic research collaboration was signed on January 7 by Chi-Hung Lin, President of National Yang Ming Chiao Tung University (NYCU); Chin-Yung Hsu, Chairman of Heron; and Chai-Wu Liu, CEO of the Jumin Foundation. As part of this landmark agreement, NYCU will introduce a 7T MRI system, while Heron plans to construct the “Boron Neutron Capture Therapy (BNCT) and Advanced Imaging Center” at the Bo-Ai Campus. Jumin Hospital will serve as the essential platform and backbone for innovative medical R&D.